
Market
Evvy secures $40m to validate AI-based women’s health diagnostics
Evvy raised $40 million in Series B funding to advance its AI-powered diagnostic platform for women's health. The round was oversubscribed, marking a significant capital infusion for the company to validate its diagnostic models and expand its care offerings in the women's health sector.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network